{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:40:01Z","timestamp":1771472401998,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fund for 1000 Youth Talents","award":["No.2013-RSQ02"],"award-info":[{"award-number":["No.2013-RSQ02"]}]},{"name":"Science and Technology Program","award":["No.Z161100000516154"],"award-info":[{"award-number":["No.Z161100000516154"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81570276"],"award-info":[{"award-number":["No.81570276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00438-019-01578-4","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T23:03:24Z","timestamp":1558220604000},"page":"1241-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The co-segregation of the MYL2 R58Q mutation in Chinese hypertrophic cardiomyopathy family and its pathological effect on cardiomyopathy disarray"],"prefix":"10.1007","volume":"294","author":[{"given":"Kunlun","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianmei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7674-9857","authenticated-orcid":false,"given":"Zhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,18]]},"reference":[{"key":"1578_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/CIRCRESAHA.111.242974","volume":"109","author":"H Ashrafian","year":"2011","unstructured":"Ashrafian H, McKenna WJ, Watkins H (2011) Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. Circ Res 109:86\u201396","journal-title":"Circ Res"},{"key":"1578_CR2","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Authors\/Task Force m, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733\u20132779","journal-title":"Eur Heart J"},{"key":"1578_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrg3938","volume":"16","author":"OG Bahcall","year":"2015","unstructured":"Bahcall OG (2015) Genetic testing. ACMG guides on the interpretation of sequence variants. Nat Rev Genet 16:256\u2013257","journal-title":"Nat Rev Genet"},{"key":"1578_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/ng1092-157","volume":"2","author":"A de la Chapelle","year":"1992","unstructured":"de la Chapelle A, Tolvanen R, Boysen G, Santavy J, Bleeker-Wagemakers L, Maury CP, Kere J (1992) Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet 2:157\u2013160","journal-title":"Nat Genet"},{"key":"1578_CR6","doi-asserted-by":"publisher","first-page":"1575130","DOI":"10.1155\/2016\/1575130","volume":"2016","author":"PP Dimitrow","year":"2016","unstructured":"Dimitrow PP, Rajtar-Salwa R (2016) Obstructive form of hypertrophic cardiomyopathy-left ventricular outflow tract gradient: novel methods of provocation, monitoring of biomarkers, and recent advances in the treatment. Biomed Res Int 2016:1575130","journal-title":"Biomed Res Int"},{"key":"1578_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s001090050210","volume":"76","author":"J Flavigny","year":"1998","unstructured":"Flavigny J, Richard P, Isnard R, Carrier L, Charron P, Bonne G, Forissier JF, Desnos M, Dubourg O, Komajda M, Schwartz K, Hainque B (1998) Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J Mol Med (Berl) 76:208\u2013214","journal-title":"J Mol Med (Berl)"},{"key":"1578_CR8","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","volume":"124","author":"BJ Gersh","year":"2011","unstructured":"Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW, American College of Cardiology Foundation\/American Heart Association Task Force on Practice G, American Association for Thoracic S, American Society of E, American Society of Nuclear C, Heart Failure Society of A, Heart Rhythm S, Society for Cardiovascular A, Interventions, Society of Thoracic S (2011) 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 124:2761\u20132796","journal-title":"Circulation"},{"key":"1578_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1042\/bj2720827","volume":"272","author":"J Ghiso","year":"1990","unstructured":"Ghiso J, Haltia M, Prelli F, Novello J, Frangione B (1990) Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 272:827\u2013830","journal-title":"Biochem J"},{"key":"1578_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.yjmcc.2008.09.126","volume":"46","author":"MJ Greenberg","year":"2009","unstructured":"Greenberg MJ, Watt JD, Jones M, Kazmierczak K, Szczesna-Cordary D, Moore JR (2009) Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics. J Mol Cell Cardiol 46:108\u2013115","journal-title":"J Mol Cell Cardiol"},{"key":"1578_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.abb.2016.02.022","volume":"601","author":"W Huang","year":"2016","unstructured":"Huang W, Kazmierczak K, Zhou Z, Aguiar-Pulido V, Narasimhan G, Szczesna-Cordary D (2016) Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain. Arch Biochem Biophys 601:121\u2013132","journal-title":"Arch Biochem Biophys"},{"key":"1578_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/sj.ejhg.5200872","volume":"10","author":"ZT Kabaeva","year":"2002","unstructured":"Kabaeva ZT, Perrot A, Wolter B, Dietz R, Cardim N, Correia JM, Schulte HD, Aldashev AA, Mirrakhimov MM, Osterziel KJ (2002) Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy. Eur J Hum Genet 10:741\u2013748","journal-title":"Eur J Hum Genet"},{"key":"1578_CR14","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.jacc.2010.12.036","volume":"57","author":"JD Kapplinger","year":"2011","unstructured":"Kapplinger JD, Landstrom AP, Salisbury BA, Callis TE, Pollevick GD, Tester DJ, Cox MG, Bhuiyan Z, Bikker H, Wiesfeld AC, Hauer RN, van Tintelen JP, Jongbloed JD, Calkins H, Judge DP, Wilde AA, Ackerman MJ (2011) Distinguishing arrhythmogenic right ventricular cardiomyopathy\/dysplasia-associated mutations from background genetic noise. J Am Coll Cardiol 57:2317\u20132327","journal-title":"J Am Coll Cardiol"},{"key":"1578_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/CIRCRESAHA.116.309804","volume":"119","author":"T Kraft","year":"2016","unstructured":"Kraft T, Montag J, Radocaj A, Brenner B (2016) Hypertrophic cardiomyopathy: cell-to-cell imbalance in gene expression and contraction force as trigger for disease phenotype development. Circ Res 119:992\u2013995","journal-title":"Circ Res"},{"key":"1578_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92:785\u2013789","journal-title":"Circulation"},{"key":"1578_CR17","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","volume":"114","author":"MS Maron","year":"2006","unstructured":"Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232\u20132239","journal-title":"Circulation"},{"key":"1578_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0022-2828(03)00146-9","volume":"35","author":"S Morner","year":"2003","unstructured":"Morner S, Richard P, Kazzam E, Hellman U, Hainque B, Schwartz K, Waldenstrom A (2003) Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J Mol Cell Cardiol 35:841\u2013849","journal-title":"J Mol Cell Cardiol"},{"key":"1578_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.yjmcc.2009.11.004","volume":"48","author":"P Muthu","year":"2010","unstructured":"Muthu P, Mettikolla P, Calander N, Luchowski R, Gryczynski I, Gryczynski Z, Szczesna-Cordary D, Borejdo J (2010) Single molecule kinetics in the familial hypertrophic cardiomyopathy D166V mutant mouse heart. J Mol Cell Cardiol 48:989\u2013998","journal-title":"J Mol Cell Cardiol"},{"key":"1578_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/BF02066413","volume":"1","author":"S Nunoda","year":"1985","unstructured":"Nunoda S, Genda A, Sekiguchi M, Takeda R (1985) Left ventricular endomyocardial biopsy findings in patients with essential hypertension and hypertrophic cardiomyopathy with special reference to the incidence of bizarre myocardial hypertrophy with disorganization and biopsy score. Heart Vessels 1:170\u2013175","journal-title":"Heart Vessels"},{"key":"1578_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/cvr\/cvv024","volume":"105","author":"I Olivotto","year":"2015","unstructured":"Olivotto I, d\u2019Amati G, Basso C, Van Rossum A, Patten M, Emdin M, Pinto Y, Tomberli B, Camici PG, Michels M (2015) Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations. Cardiovasc Res 105:409\u2013423","journal-title":"Cardiovasc Res"},{"key":"1578_CR22","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s10554-016-0929-6","volume":"32","author":"J Peyrou","year":"2016","unstructured":"Peyrou J, Reant P, Reynaud A, Cornolle C, Dijos M, Rooryck-Thambo C, Landelle M, Montaudon M, Laurent F, Roudaut R, Lafitte S (2016) Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography. Int J Cardiovasc Imaging 32:1379\u20131389","journal-title":"Int J Cardiovasc Imaging"},{"key":"1578_CR23","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.amjcard.2009.01.356","volume":"103","author":"X Qiu","year":"2009","unstructured":"Qiu X, Liu W, Hu D, Zhu T, Li C, Li L, Guo C, Liu X, Wang L, Zheng H, Wang C, Diao Q, Shi D, Zhan P, Deng Y, Liu K, Wang Y, Liu B, Liu H, Zhang L (2009) Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Am J Cardiol 103:1439\u20131444","journal-title":"Am J Cardiol"},{"key":"1578_CR24","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","volume":"107","author":"P Richard","year":"2003","unstructured":"Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M, Project EHF (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107:2227\u20132232","journal-title":"Circulation"},{"key":"1578_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"key":"1578_CR26","doi-asserted-by":"publisher","first-page":"270ra276","DOI":"10.1126\/scitranslmed.3010134","volume":"7","author":"AM Roberts","year":"2015","unstructured":"Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG, Buchan RJ, Walsh R, John S, Wilkinson S, Mazzarotto F, Felkin LE, Gong S, MacArthur JA, Cunningham F, Flannick J, Gabriel SB, Altshuler DM, Macdonald PS, Heinig M, Keogh AM, Hayward CS, Banner NR, Pennell DJ, O\u2019Regan DP, San TR, de Marvao A, Dawes TJ, Gulati A, Birks EJ, Yacoub MH, Radke M, Gotthardt M, Wilson JG, O\u2019Donnell CJ, Prasad SK, Barton PJ, Fatkin D, Hubner N, Seidman JG, Seidman CE, Cook SA (2015) Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med 7:270ra276","journal-title":"Sci Transl Med"},{"key":"1578_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, Maron BJ (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65:1249\u20131254","journal-title":"J Am Coll Cardiol"},{"key":"1578_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gene.2015.06.027","volume":"569","author":"F Sheikh","year":"2015","unstructured":"Sheikh F, Lyon RC, Chen J (2015) Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease. Gene 569:14\u201320","journal-title":"Gene"},{"key":"1578_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/hrt.55.6.575","volume":"55","author":"M Tanaka","year":"1986","unstructured":"Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C (1986) Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 55:575\u2013581","journal-title":"Br Heart J"},{"key":"1578_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/heart.84.5.476","volume":"84","author":"AM Varnava","year":"2000","unstructured":"Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476\u2013482","journal-title":"Heart"},{"key":"1578_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jmb.2006.06.018","volume":"361","author":"Y Wang","year":"2006","unstructured":"Wang Y, Xu Y, Kerrick WG, Wang Y, Guzman G, Diaz-Perez Z, Szczesna-Cordary D (2006) Prolonged Ca2+\u2009and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations. J Mol Biol 361:286\u2013299","journal-title":"J Mol Biol"},{"key":"1578_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.yjmcc.2013.05.012","volume":"62","author":"L Wang","year":"2013","unstructured":"Wang L, Muthu P, Szczesna-Cordary D, Kawai M (2013) Diversity and similarity of motor function and cross-bridge kinetics in papillary muscles of transgenic mice carrying myosin regulatory light chain mutations D166V and R58Q. J Mol Cell Cardiol 62:153\u2013163","journal-title":"J Mol Cell Cardiol"},{"key":"1578_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/febs.14702","volume":"286","author":"S Yadav","year":"2018","unstructured":"Yadav S, Kazmierczak K, Liang J, Sitbon YH, Szczesna-Cordary D (2018) Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain. FEBS J 286:151\u2013168","journal-title":"FEBS J"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-019-01578-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00438-019-01578-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-019-01578-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:27:34Z","timestamp":1589671654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00438-019-01578-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,18]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1578"],"URL":"https:\/\/doi.org\/10.1007\/s00438-019-01578-4","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,18]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Kunlun Yin declares that he has no conflict of interest. Yi Ma declares that she has no conflict of interest. Hao Cui declares that he has no conflict of interest. Yang Sun declares that she has no conflict of interest. Bianmei Han declares that she has no conflict of interest. Xuewen Liu declares that she has no conflict of interest. Kun Zhao declares that she has no conflict of interest. Wenke Li declares that he has no conflict of interest. Jingjin Wang declares that she has no conflict of interest. Hongyue Wang declares that he has no conflict of interest. Shuiyun Wang declares that he has no conflict of interest. Zhou Zhou declares that he has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of the institutional review board at Fuwai Hospital. Informed consent was obtained from all individual participants included in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}